Growth Metrics

Rigel Pharmaceuticals (RIGL) Enterprise Value (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.34%
Dec 31, 2025 -12.99%
Sep 30, 2025 -26.54%
Jun 30, 2025 -40.57%
Mar 31, 2025 0.29%
Dec 31, 2024 -26.52%
Sep 30, 2024 -24.46%
Jun 30, 2024 0.90%
Mar 31, 2024 12.97%
Dec 31, 2023 8.69%
Sep 30, 2023 3.12%
Jun 30, 2023 -9.71%
Mar 31, 2023 -0.78%
Dec 31, 2022 28.71%
Sep 30, 2022 8.44%
Jun 30, 2022 17.07%
Mar 31, 2022 13.96%
Dec 31, 2021 12.70%
Sep 30, 2021 6.68%
Jun 30, 2021 -289.85%
Mar 31, 2021 31.37%
Dec 31, 2020 21.27%
Sep 30, 2020 21.28%
Jun 30, 2020 3.57%
Mar 31, 2020 2.19%
Dec 31, 2019 8.75%
Sep 30, 2019 4.36%
Jun 30, 2019 12.15%
Mar 31, 2019 0.48%
Dec 31, 2018 -11.16%
Sep 30, 2018 14.34%
Jun 30, 2018 -43.15%
Mar 31, 2018 18.53%
Dec 31, 2017 -70.03%
Sep 30, 2017 17.29%
Jun 30, 2017 16.14%
Mar 31, 2017 -31.26%
Dec 31, 2016 12.30%
Sep 30, 2016 10.20%
Jun 30, 2016 8.39%
Mar 31, 2016 17.93%
Dec 31, 2015 6.01%
Sep 30, 2015 6.66%
Jun 30, 2015 10.68%
Mar 31, 2015 -12.57%
Dec 31, 2014 9.20%
Sep 30, 2014 10.43%
Jun 30, 2014 9.91%
Mar 31, 2014 7.83%
Dec 31, 2013 8.19%
Sep 30, 2013 8.25%
Jun 30, 2013 7.64%
Mar 31, 2013 8.65%
Dec 31, 2012 -62.18%
Sep 30, 2012 9.25%
Jun 30, 2012 9.25%
Mar 31, 2012 9.83%
Dec 31, 2011 6.79%
Sep 30, 2011 4.81%
Jun 30, 2011 -985.73%
Mar 31, 2011 85.50%
Dec 31, 2010 -703.77%
Sep 30, 2010 31.56%